AzTrials
AzTrials

Palatal WoundNCT07089433

Palatal Shield Technique for Graft Donor Site Healing

A study testing Palatal stent as wound dressing and Conventional suturing in people with Palatal Wound, run by University of Cagliari at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized clinical trial aims to compare two techniques for managing the palatal donor site following gingival graft harvesting: a palatal stent made of flowable composite resin versus conventional suturing. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Palatal Wound
What is being tested?
Palatal stent as wound dressing and Conventional suturing
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteItaly
Study dates
1 Jul 2023to 15 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Adult patients (≥18 years old) requiring periodontal or peri-implant mucogingival surgery involving palatal graft harvesting.
  • Systemically healthy patients without medical conditions affecting wound healing.
  • Patients free of active periodontal disease at the time of surgery.
  • Patients able and willing to comply with postoperative instructions, complete questionnaires, and attend follow-up appointments.
  • Patients providing informed written consent to participate in the study.

Who cannot join

  • Patients with systemic diseases that could influence wound healing (e.g., diabetes, autoimmune disorders).
  • Patients with active periodontal disease.
  • Patients taking medications known to affect bleeding or healing (e.g., anticoagulants, immunosuppressants, steroids).
  • Patients who are pregnant or breastfeeding.
  • Patients who have undergone previous surgical interventions in the palatal donor area.
  • Patients with allergies or hypersensitivity to composite resin materials or collagen-based products.
  • Patients unable or unwilling to comply with postoperative instructions or follow-up visits.
  • Patients with poor oral hygiene or uncontrolled plaque accumulation.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Cagliari University Hospital

    Cagliari, Cagliari, 09042

Other trials in Italy

About this study

Official title: Morbidity Following Free Gingival Graft Harvesting With or Without the Use of the Palatal Shield Technique as a Wound Dressing: A Randomized Trial

This randomized clinical trial aims to compare two techniques for managing the palatal donor site following gingival graft harvesting: a palatal stent made of flowable composite resin versus conventional suturing. The primary goal is to identify which method provides superior patient-reported outcomes (PROMs), thus optimizing postoperative comfort and overall patient well-being.

Systemically healthy patients, free of active periodontitis, requiring a palatal graft as part of periodontal or peri-implant mucogingival surgeries will be recruited and randomized into two groups. The experimental group will receive a palatal shield made of flowable composite resin adhesively secured to adjacent teeth, whereas the control group will undergo conventional suturing. In both groups, a collagen hemostatic sponge will be placed to aid hemostasis.

Read more

Primary endpoints include postoperative pain measured daily via Visual Analog Scale (VAS), general patient comfort during daily activities such as eating and oral hygiene, and overall patient satisfaction assessed using Likert scales or validated questionnaires.

Secondary endpoints involve clinical healing evaluated clinically and photographically at 7 and 14 days postoperatively, incidence of postoperative complications (e.g., prolonged bleeding, infections), analgesic consumption, functional recovery time, and oral health-related quality of life measured by the OHIP-14 questionnaire.

Statistical analysis will compare groups using appropriate parametric or non-parametric tests for continuous variables (pain scores, recovery time) and Chi-square or Fisher's exact tests for categorical variables. Pain progression over time will be assessed using repeated-measures ANOVA or an equivalent non-parametric test.

This study will help determine whether the palatal stent represents a superior alternative to conventional techniques in improving patient comfort, healing, and postoperative oral health-related quality of life in mucogingival surgical procedures.

Read the detailed description

Objective This study aims to compare the effectiveness of palatal stent management versus conventional suturing on patient-reported outcome measures (PROMs), to identify the optimal strategy for managing palatal donor sites and improving postoperative patient well-being.

Primary Endpoints

  • Postoperative Pain: Measured daily using a Visual Analog Scale (VAS) during the first postoperative week.
  • General Patient Comfort: Evaluated using standardized questionnaires assessing discomfort during daily activities such as eating and oral hygiene.
  • Patient Satisfaction: Assessed using Likert scales or validated questionnaires.

Secondary Endpoints

  • Clinical Healing of Donor Site: Evaluated clinically (e.g., redness, swelling, infection signs) and photographically at 7 and 14 days postoperatively.
  • Postoperative Complications: Frequency of events including prolonged bleeding, infection, or need for additional intervention.
  • Analgesic Use: Number and duration of analgesic doses prescribed or voluntarily taken by patients.
  • Functional Recovery Time: Days required for patients to resume normal activities (e.g., eating without difficulty, returning to work).
  • Oral Health-Related Quality of Life: Evaluated using standardized questionnaires such as OHIP-14.

Study Design

Eligible patients will be recruited and randomized into two groups:

  • Experimental Group: Palatal shield management using flowable composite resin secured by adhesion to the palatal surfaces of adjacent teeth.
  • Control Group: Conventional suturing management.

Prior to the procedure, baseline clinical information including plaque index and bleeding index will be collected, and informed consent will be obtained from each patient.

Surgical Procedure Free gingival graft harvesting will be performed from the palate according to standard surgical techniques. The recipient surgical procedure is not within the scope of this study and will not influence the outcomes. In both groups, collagen sponge hemostatic dressing will be secured on the donor site using either resin or sutures.

Postoperative Care All patients will receive standardized postoperative instructions, including oral hygiene and pain management guidelines, along with analgesic prescriptions as needed. Follow-up evaluations will be conducted at 1 and 2 weeks postoperatively to assess pain (VAS), complications, and healing status. Patients will complete standardized questionnaires measuring comfort, satisfaction, and oral health-related quality of life.

Inclusion Criteria Systemically healthy patients without active periodontitis requiring periodontal or peri-implant mucogingival surgery involving palatal graft harvesting.

Independent Variables

  • Donor Site Management Technique:
  • Palatal stent (Experimental group)
  • Conventional suture (Control group)

Dependent Variables

  • Postoperative pain (VAS)
  • Perceived comfort (standardized questionnaires)
  • Clinical healing (clinical observations)
  • Postoperative complications
  • Analgesic consumption
  • Functional recovery time
  • Patient satisfaction
  • Oral health-related quality of life (OHIP-14)

Confounding Variables

  • Patient age
  • Gender
  • Smoking status
  • Graft dimensions (width and depth)

Statistical Analysis Data will be analyzed using appropriate statistical methods to compare both groups. Continuous variables, such as pain scores and recovery time, will be analyzed using independent samples t-test or Mann-Whitney U test based on data distribution. Categorical variables, such as complications and analgesic use, will be evaluated using Chi-square or Fisher's exact test. Pain evolution over time will be assessed using repeated-measures ANOVA or non-parametric equivalents. Quality of life questionnaires (OHIP-14) and patient satisfaction scores will be analyzed using descriptive statistics and between-group comparisons.

Conditions
Palatal Wound
Being tested
Palatal stent as wound dressing, Conventional suturing
Keywords
Free gingival graft, Wound healing, palatal stent

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Palatal stent as wound dressingProcedure or surgery

    The palatal wound after graft harvesting will be protected with a flowable composite resin adhesively secured to adjacent teeth

  • Conventional suturingProcedure or surgery

    The wound will be covered with a collagen sponge that will be hold in place with sutures

Study groups in NCT07089433
Study groupRoleWhat they receive
TestExperimentalThe palatal wound will be protected with composite resin
Receives: Procedure: Palatal stent as wound dressing
ControlActive comparatorThe palatal wound will be covered with collagen sponge
Receives: Procedure: Conventional suturing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain

    Measured daily using a Visual Analog Scale (VAS) during the first postoperative week.

    Measured: The day of the intervention and every day for the first week

  2. General Patient Comfort

    Evaluated using standardized questionnaires assessing discomfort during daily activities such as eating and oral hygiene

    Measured: The day of the intervention, every day during the first week and 14 days after the intervention

  3. Patient Satisfaction

    Assessed using Likert scales and validated questionnaires

    Measured: The day of the intervention, every day during the first week and 14 days after the intervention

Secondary outcomes (5)
  1. Clinical Healing of Donor Site

    Evaluated clinically (e.g., redness, swelling, infection signs) and photographically.

    Measured: At 7 and 14 days postoperatively.

  2. Postoperative Complications

    Frequency of events including prolonged bleeding, infection, or need for additional intervention

    Measured: Every day during the first week

  3. Analgesic Use

    Number and duration of analgesic doses prescribed or voluntarily taken by patients

    Measured: Day of the intervention and every day during the first week.

  4. Functional Recovery Time

    Days required for patients to resume normal activities (e.g., eating without difficulty, returning to work).

    Measured: Every day during the first week and at day 14

  5. Oral Health-Related Quality of Life

    Evaluated using standardized questionnaires such as OHIP-14.

    Measured: At day 14

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2025
  2. Study start1 Jul 2023
  3. Primary completion30 Apr 2025
  4. Study completion15 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07089433
Sponsor's protocol ID
Palatal Shield
Status last verified
Jul 2025
First submitted
20 Jul 2025
Last updated
28 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Palatal stent as wound dressing and Conventional suturing in people with Palatal Wound, run by University of Cagliari at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain (time frame: The day of the intervention and every day for the first week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in